Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma

Journal of Clinical Oncology

Volumn 25, Issue 15, 2007, Pages 1974-1978

  Brewster, Abenaa M ^b   Lee, J Jack ^b   Clayman, Gary L ^b   Clifford, John L ^b   Reyes, Mary Jo T Necesito ^b   Zhou, Xian ^b   Sabichi, Anita L ^b   Strom, Sara S ^b   Collins, Robert ^b   Meyers, Christina A ^b   Lippman, Scott M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ISOTRETINOIN; ALPHA2A INTERFERON; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTHRALGIA; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CHEILITIS; CHILL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DRY EYE; DRY SKIN; FATIGUE; FEMALE; FEVER; FOLLOW UP; HUMAN; LIP DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYALGIA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; ADJUVANT CHEMOTHERAPY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; SECOND CANCER; SKIN TUMOR; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; INTERFERON ALFA-2A; ISOTRETINOIN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; PROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 34249938990     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.05.9873     Document Type: Article

References (19)

1. Jemal A, Murray T, Ward E, et al: Cancer statistics, 2005. CA Cancer J Clin 55:10-30, 2005
2. Alam M, Ratner D: Cutaneous squamous-cell carcinoma. N Engl J Med 344:975-983, 2001
3. Clayman GL, Lee JJ, Holsinger FC, et al: Mortality risk from squamous cell skin cancer. J Clin Oncol 23:759-765, 2005
4. Rowe DE, Carroll RJ, Day CL Jr: Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: Implications for treatment modality selection. J Am Acad Dermatol 26:976-990, 1992
5. Veness MJ, Palme CE, Smith M, et al: Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): A better outcome with surgery and adjuvant radiotherapy. Laryngoscope 113:1827-1833, 2003
6. Garcia-Serra A, Hinerman RW, Mendenhall WM, et al: Carcinoma of the skin with perineural invasion. Head Neck 25:1027-1033, 2003
7. Lippman SM, Parkinson DR, Itri LM, et al: 13-cis-retinoic acid and interferon alpha-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 84:235-241, 1992
8. Lippman SM, Kavanagh JJ, Paredes-Espinoza M, et al: 13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix. J Natl Cancer Inst 85:499-500, 1993
9. Weber R, Lippman SM, McNeese M: Advanced basal and squamous cell carcinomas of the skin of the head and neck, in Jacobs C (ed): Carcinomas of the Head and Neck: Evaluation and Management. Boston, MA, Kluwer Academic, 1990
10. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
11. Hess KR, Serachitopol DM, Brown BW: Hazard function estimators: A simulation study. Stat Med 18:3075-3088, 1999
12. Shin DM, Glisson BS, Khuri FR, et al: Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer. J Clin Oncol 20:364-370, 2002
13. Sun SY, Lotan R: Retinoids and their receptors in cancer development and chemoprevention. Crit Rev Oncol Hematol 41:41-55, 2002
14. Clifford JL, Walch E, Yang X, et al: Suppression of type I interferon signaling proteins is an early event in squamous skin carcinogenesis. Clin Cancer Res 8:2067-2072, 2002
15. Yaar M, Karassik RL, Schnipper LE, et al: Effects of alpha and beta interferons on cultured human keratinocytes. J Invest Dermatol 85:70-74, 1985
16. Rodriguez-Villanueva J, McDonnell TJ: Induction of apoptotic cell death in non-melanoma skin cancer by interferon-alpha. Int J Cancer 61:110-114, 1995
17. Clifford JL, Yang X, Walch E, et al: Dominant negative signal transducer and activator of transcription 2 (STAT2) protein: Stable expression blocks interferon alpha action in skin squamous cell carcinoma cells. Mol Cancer Ther 2:453-459, 2003
18. Parmar S, Platanias LC: Interferons: Mechanisms of action and clinical applications. Curr Opin Oncol 15:431-439, 2003
19. Kalvakolanu DV, Borden EC: An overview of the interferon system: Signal transduction and mechanisms of action. Cancer Invest 14:25-53, 1996